Amdocs (NASDAQ:DOX) Director Yvette Kanouff Purchases 2,400 Shares of Stock

Amdocs Limited (NASDAQ:DOX) Director Yvette Kanouff bought 2,400 shares of the firm’s stock in a transaction that occurred on Monday, November 9th. The shares were purchased at an average cost of $42.00 per share, with a total value of $100,800.00. Following the transaction, the director directly owned 26,600 shares of the company’s stock, valued at $1,117,200. The trade was a 9.92% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Amdocs Price Performance

NASDAQ DOX opened at $44.11 on Friday. Amdocs Limited has a 12-month low of $39.96 and a 12-month high of $84.95. The firm’s fifty day simple moving average is $57.88 and its two-hundred day simple moving average is $61.17. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $4.76 billion, a P/E ratio of 6.50, a P/E/G ratio of 1.40 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The firm had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter last year, the firm earned $1.83 EPS. The business’s quarterly revenue was up 3.8% on a year-over-year basis. Analysts forecast that Amdocs Limited will post 5.82 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be paid a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 5.2%. Amdocs’s payout ratio is presently 48.82%.

Institutional Trading of Amdocs

Several hedge funds and other institutional investors have recently bought and sold shares of DOX. First Trust Advisors LP increased its stake in shares of Amdocs by 18.7% in the 3rd quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company’s stock valued at $93,652,000 after purchasing an additional 258,098 shares in the last quarter. Advisors Asset Management Inc. purchased a new position in Amdocs during the third quarter worth approximately $40,432,000. Composition Wealth LLC purchased a new stake in shares of Amdocs in the third quarter valued at approximately $309,000. Voya Investment Management LLC lifted its position in shares of Amdocs by 155.6% during the 3rd quarter. Voya Investment Management LLC now owns 28,213 shares of the technology company’s stock valued at $1,613,000 after buying an additional 17,173 shares in the last quarter. Finally, Public Sector Pension Investment Board purchased a new position in shares of Amdocs during the 3rd quarter valued at approximately $3,281,000. 92.02% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DOX has been the topic of several research analyst reports. Zacks Research downgraded shares of Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Oppenheimer lowered Amdocs from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Finally, Stifel Nicolaus decreased their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a report on Wednesday, November 4th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $69.00.

Latest Amdocs News

These are some of the DOX news items that stood out recently:

• Positive Sentiment: Three directors reported open-market purchases between November 9 and 10, including Yvette Kanouff’s $100,800 purchase and John Anthony Macdonald’s $41,630 purchase. Insider buying may signal confidence, though it does not resolve the company’s operating challenges. SEC filing for Yvette Kanouff purchase SEC filing for Veronique Morali purchase SEC filing for John Anthony Macdonald purchase
• Negative Sentiment: Zacks Research downgraded Amdocs from “hold” to “strong sell,” adding to negative sentiment after the steep selloff. Zacks Research ratings
• Negative Sentiment: The November 4 plunge followed disappointing fiscal 2027 guidance linked to an escalating T-Mobile dispute, despite quarterly results coming in line with expectations. Multiple law firms have since announced investigations into potential securities claims or alleged misleading disclosures. These are investigations, not findings of wrongdoing, but could add uncertainty and reputational risk. Levi & Korsinsky notice Pomerantz investigation notice Rosen Law investigation notice

About Amdocs

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.